HTL Clinical is a full-service histopathology contract research organization (CRO) offering medically relevant non-clinical and clinical services to the pharmaceutical, biotech, and academic communities. The company was formed as a new venture, resulting from the extensive growth and loyalty of clients of HistoTox Labs, a premier non-clinical CRO which has been providing high quality histology, pathology, digital pathology, and immunohistochemistry (IHC) services for more than 16 years. Our CLIA-compliant facility resides in a newly renovated 16,200 square foot space in Boulder, Colorado.
HTL Clinical is proud to be born from a group that is so highly recognized for their exceptional capabilities and expertise in immunohistochemistry (IHC). The organizations consistently add to their vast library of optimized antibodies and are supported by a highly trained scientific staff. We continue to grow these teams by adding new, qualified technicians, by providing additional training, quality oversight, a healthy culture and the newest equipment available. As a valuable compliment to the IHC services, HTL Clinical also offers the latest technology with an AT2 (Aperio) high-throughput slide scanner and the well-respected, versatile Visiopharm image analysis software.
The company remains committed to growing their capabilities to support routine and specialized IHC, histopathology and digital pathology. Our team of experts is comprised of board-certified DVM and MD pathologists, trained histotechnicians, scientists, project managers, and hands-on upper management. With our primary focus in oncology, we provide substantiated expertise in clinical trial services and laboratory diagnostics to enable confident, data-driven decisions.
There is an ongoing commitment to operate in a highly efficient manner to save YOU time and expense. Our team understands the importance of your programs and is focused on doing what it takes to deliver exceptional quality on a timely basis.
HTL Clinical has not received any reviews.
HTL Clinical has not received any endorsements.